Market Overview

Alnylam Pharma Reports Offering of $125M in Stock

Related ALNY
Exclusive: Dicerna CEO Talks Goals For 2017, Competitors And Prospects Under Trump
Alnylam's Healthy Earnings Boost Price, Prompts Vetr Users To Call Hold
The Vetr community has upgraded $ALNY to 4.5-Stars. (Vetr)

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading RNAi therapeutics company, today announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $125 million. All of the shares in the offering are to be sold by Alnylam.

Posted-In: News Offerings


Related Articles (ALNY)

View Comments and Join the Discussion!